BioServe SNPlate™ Plates
Pre assembled Case-Control Studies
Screening DNA from groups of disease cases and disease-free controls is the most common method to identify genetic markers of disease and to identify novel gene targets for treatment.
BioServe has developed SNPlates™ to help researchers cost-effectively validate these markers. SNPlates™ are pre-aliquotted 180:180 data-rich patient samples to perform case-control studies. These case control studies on a plate were designed by genetic epidemiologists to identify and validate genetic markers of disease and to validate previously identified genetic markers in specific disease states.
High Cost of Case-Control Studies:
- Specialized personnel such as physicians, epidemiologists, biostatisticians, database developers, interviewers, phlebotomists, IRB coordinators and biorepository managers in order to identify and process samples
- Infrastructure required including laboratories, freezers, LIMS.
- Cost value of time required to organize, collect, and prepare samples for analysis
High Value Samples and Clinical Data:
- Samples mined from BioServe's Global Repository of over 140,000 clinically annotated DNA samples of various diseases with detailed demographic, smoking, diet, and clinical data
- Cases matched to controls based on age, gender, race and body mass index
- SNPlates™ are representative of the larger population of subject available in the BioServe Global Repository
- All samples have passed rigorous quality control tests including genotyping for 10 SNPs
SNPlate Technical Specifications
- All subjects provided informed consent and samples were collected using an IRB approved, HIPAA compliant protocol
- 25ng of Lyophilized DNA samples delivered in 96-well or 384-well plates
- Comprehensive demographic and clinical data delivered with SNPlate
- Click below for a sampling of patient data:
Breast Cancer
Prostate Cancer
Lung Cancer
Diabetes
Obesity
For ordering and collaboration opportunities, please submit the SNPlate™ information request form below.
|
